Anthem’s Obamacare exit could leave 300,000 without options
The loss of another insurer in the program would put more pressure on Republicans in Congress who are attempting to repeal and replace large parts of Obamacare.
Bloomberg News
Articles
High court justices limit recovery in securities fraud cases
The Supreme Court on Monday made it tougher for the government to recover ill-gotten gains from people convicted of securities fraud, ruling that such recoveries are subject to a five-year statute of limitations.
Trump making push for air-traffic, infrastructure plans
President Donald Trump on Monday unveiled his proposal to hand over control of the U.S. air-traffic control system to a not-for-profit corporation as he kicked off a week-long push for his $1 trillion infrastructure plan.
Drugmakers brace for Trump proposals to tackle U.S. prices
Top pharmaceutical CEOs say they expect President Donald Trump, a frequent critic of industry pricing practices, to take steps soon to address high U.S. drug costs.
Rise in female VC partners doesn’t lead to more women getting funded
A new Bloomberg analysis shows that venture capital firms with senior women partners backed companies founded or co-founded by women at roughly the same rate as VC firms with no senior women partners.
Health overhaul would leave 23M more uninsured by 2026, CBO says
The bill to repeal and partially replace Obamacare would reduce the deficit by $119 billion over 10 years, the Congressional Budget Office said.
Target settles data-breach lawsuit with 47 states for $18.5M
Indiana will be among the states receiving money to settle state lawsuits over a 2013 hack of the retailer’s database in which the personal information of millions of customers was stolen.
Shopping mall executives say gloomy future has been exaggerated
Retailers and shopping-center owners are gathering in Las Vegas this week prepared to send a message: The American mall is doing better than many people think.
Carmel-based company wins patent case at U.S. Supreme Court
The justices ruled unanimously Monday that patent infringement lawsuits can be filed only in states where defendants are incorporated. The case was sparked by an appeal from Carmel-based TC Heartland LLC.
Ford ousts CEO, taps head of autonomous-vehicle unit as successor
The departure of Mark Fields comes amid sharp criticism of Ford's strategy by shareholders, and a more than 30 percent plunge in the company's stock price during his tenure.
Pence takes steps to build war chest amid White House controversy
Indiana's former governor launched Great America Committee, a leadership PAC, a move that will enable him to channel money to congressional Republicans ahead of the 2018 midterm elections.
Sears CEO lashes out at suppliers trying to ‘take advantage’
Sears Holdings Corp. CEO Eddie Lampert vowed to fight back against suppliers trying to take advantage of his company, saying that “dire predictions” about the struggling retailer’s future have hurt its position with vendors.
Few victims paying hackers because of difficulty using bitcoin
An unprecedented cyberattack swept across the globe over the weekend, but so far the majority of victims haven’t paid hackers a ransom.
High court backs bids to collect outdated debt in bankruptcy
A divided U.S. Supreme Court has ruled that debt collectors can use bankruptcy proceedings to try to collect liabilities that are so old the statute of limitations has expired.
New wave of ransom threats seen in unprecedented attack
More than 200,000 computers in at least 150 countries have so far been infected, according to the European Union’s law enforcement agency. The U.K.’s National Cyber Security Centre said new cases of so-called ransomware are possible “at a significant scale.”
Anthem abandons battle for Cigna after court deals blow to deal
Anthem says it is giving up on the $48 billion purchase in the wake of a Thursday court ruling giving Cigna the right to walk away. The Indianapolis-based insurer says Cigna is not entitled to collect a $1.85 billion breakup fee.
Lilly migraine drug provides relief in late-stage trials
Lilly is in a race with several pharmaceutical firms to develop migraine treatments using an approach known as anti-CGRP and that could create a multibillion-dollar market.
Cigna wins judge’s approval to walk away from Anthem merger
The decision makes it virtually impossible for Anthem to salvage the merger and means the insurer could be on the hook for $1.85 billion in breakup fees and $13 billion in damages to Cigna.
Insurer Aetna decides to completely leave Obamacare markets
Aetna has said it expects to lose more than $200 million on individual health plans this year in the four states where it’s still selling Affordable Care Act plans.
Pharma lobbying group ousts 22 drugmakers amid U.S. pricing debate
The pharmaceutical industry’s powerful Washington, D.C., trade association, which includes Eli Lilly and Co., fell in size by almost two dozen companies after revising membership rules amid the debate over U.S. drug prices.